PhenoAge: biomarker-based biological age and mortality in a 2018 Aging paper
The description presents PhenoAge, a calculator built from nine standard blood biomarkers plus chronological age, and says a younger biological than calendar age was linked to lower all-cause mortality. [1]
Automatic summary · not editorially reviewed
The key findings
A 2018 Aging paper introduced PhenoAge, built from nine standard clinical blood biomarkers plus chronological age. [1]
The tool was derived from National Health and Nutrition Examination Survey data linked to mortality and validated in independent European and American cohorts. [1]
People whose PhenoAge was younger than their chronological age had substantially lower all-cause mortality, per the description. [1]
The source at a glance
- Study type / format
- Video description summarizing a 2018 biomarker study in the journal Aging.
- Population / context
- Adults in the survey data and validation cohorts described, including European and American populations.
- Summary based on
- Creator description
- Original publication
- September 2, 2026
PhenoAge built from nine blood biomarkers
According to the description, a paper in the journal Aging in 2018 introduced PhenoAge, short for phenotypic age. The tool combines nine standard clinical blood biomarkers with chronological age to estimate how fast or slow a person is biologically aging relative to the population. The description gives an example: two people aged sixty-five might have biological ages of fifty-eight and seventy-three. It calls understanding what that difference means, and whether it is modifiable, one of the most consequential questions in aging science.
Supporting source [1]
Derivation from survey data and validation cohorts
The description says the tool was derived from National Health and Nutrition Examination Survey data that were linked to mortality outcomes. It was then validated across multiple independent cohorts, including European and American populations. The description does not report cohort sizes, follow-up length or effect estimates.
Supporting source [1]
Younger PhenoAge and lower all-cause mortality
The description states that individuals whose PhenoAge was younger than their chronological age had substantially lower all-cause mortality. It also says the gap between biological and calendar age predicted mortality, disease risk and physical function better than calendar age alone. These are described as associations from a prediction tool, not as proof that changing biomarkers changes lifespan. The description is a video summary; the video and transcript were not reviewed, and the abstract alone does not establish causality.
Supporting source [1]
How to interpret this
This is a video description; the video and transcript were not reviewed. Cohort sizes, follow-up and effect sizes are not reported. The described links are associations from a prediction tool, not evidence that modifying biomarkers extends lifespan.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Longevity · youtube.com · September 2, 2026